Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
clinical trials
detroit blog main
detroit top stories
drugs
5
×
fda
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
investing
startups
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
cystic fibrosis
deals
eli lilly
What
bio
drug
fda
roundup
approved
disease
week
ahead
alzheimer’s
american
annual
asco
ash
assessed
attention
big
biotech
blood
branded
cancer
choices
commissioner
communities
companies
conference
consumers
costly
counterweight
country
deeper
diego
digital
dna
drugs
elevatebio
epidemic
esmo
europe
fatty
fingerprint
Language
Current search:
fda
×
drugs
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More